SCHEMBL21241980

SCHEMBL21241980

Nc1ccc(C(=O)NCC(=O)Nc2nc(-c3cccc(-c4ccccc4F)c3)cs2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 6/20 0.49
▸ HDAC3 O15379 5/20 0.49
▸ HDAC2 Q92769 5/20 0.49
▸ HDAC10 Q969S8 5/20 0.49
▸ NCOR2 Q9Y618 1/20 0.49
▸ ELOVL1 Q9BW60 2/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ HDAC6 Q9UBN7 4/20 0.47
▸ HDAC8 Q9BY41 3/20 0.47
▸ HDAC9 Q9UKV0 3/20 0.47
▸ HDAC4 P56524 2/20 0.47
▸ HDAC7 Q8WUI4 2/20 0.47
▸ HDAC11 Q96DB2 2/20 0.47
▸ HDAC5 Q9UQL6 2/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ PRKACA P17612 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22971735 0.88 HDAC1 (0.56) HDAC1HDAC3HDAC2HDAC10NCOR2
SCHEMBL21241928 0.85 SCD (0.60) HDAC1HDAC3HDAC2HDAC10ELOVL1
SCHEMBL22971635 0.85 ROCK1 (0.56) HDAC1HDAC3HDAC2HDAC10NCOR2
SCHEMBL21241936 0.85 HDAC3 (0.50) HDAC1HDAC3HDAC2HDAC10NCOR2
SCHEMBL22971654 0.85 ABL1 (0.55) HDAC1HDAC3HDAC2HDAC10NCOR2
SCHEMBL22971678 0.84 HDAC3 (0.49) HDAC1HDAC3HDAC2HDAC10NCOR2
SCHEMBL22971683 0.83 PHGDH (0.51) HDAC1HDAC3HDAC2HDAC10NCOR2
SCHEMBL21241828 0.83 HDAC3 (0.48) HDAC1HDAC3HDAC2HDAC10NCOR2
SCHEMBL21241986 0.83 PHGDH (0.51) HDAC1HDAC3HDAC2HDAC10NCOR2
SCHEMBL22971553 0.83 ROCK1 (0.54) HDAC1HDAC3HDAC2HDAC10NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230138480-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-04 — — US disclosed
US-20230138480-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-04 — — US disclosed
US-20210038611-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2021-02-11 — — US disclosed
WO-2019152437-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2019-08-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230138480-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB HDAC1 242/4885HDAC3 231/4885HDAC2 323/4885
US-20210038611-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB HDAC1 242/4885HDAC3 231/4885HDAC2 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback